Available IPD datapackage for study 'A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia'

Name: Available IPD datapackage for study 'A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia'
Creator: Vivli
Published: 2026-04-10 21:39:20
License: 暂无描述

DataCite Commons2026-04-10 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00006886.1

下载链接

链接失效反馈

官方服务：

资源简介：

The primary purpose of this study is to evaluate the overall efficacy of aripiprazole intramuscular (IM) depot as acute treatment in subjects with schizophrenia. The secondary purpose is to evaluate the safety and tolerability of aripiprazole IM depot administered every 4 weeks for 12 weeks to adult subjects with schizophrenia.

提供机构：

Vivli

创建时间：

2026-04-10